After analyzing the expression of these genes in different tumor types, we observed that IGF2BP3, NCAPG, and miR217 demonstrated higher expression in type 2 compared with type 1 KIRP (p < 0.05). The gene discussed is IGF2BP3; the disease is neoplasm.